APA (7th ed.) Citation

N, S., A, D., M, E., L, R., H, E., S, G., . . . XL, Z. (2024). Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers. Journal of clinical medicine, 13(16), . https://doi.org/10.3390/jcm13164852

Chicago Style (17th ed.) Citation

N, Sarani, et al. "Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers." Journal of Clinical Medicine 13, no. 16 (2024). https://doi.org/10.3390/jcm13164852.

MLA (9th ed.) Citation

N, Sarani, et al. "Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers." Journal of Clinical Medicine, vol. 13, no. 16, 2024, https://doi.org/10.3390/jcm13164852.